These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6395852)

  • 21. Vaccines against cholera, typhoid fever and shigellosis for developing countries.
    Acosta CJ; Galindo CM; Deen J; Ochiai R; Lee HJ; von Seidlein L; Carbis R; Clemens JD
    Expert Opin Biol Ther; 2004 Dec; 4(12):1939-51. PubMed ID: 15571456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines to prevent bacterial enteric infections in children.
    Levine MM; Noriega F
    Pediatr Ann; 1993 Dec; 22(12):719-25. PubMed ID: 8139873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].
    Cryz SJ; Fürer E; Levine MM
    Schweiz Med Wochenschr; 1988 Apr; 118(13):467-70. PubMed ID: 3375787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral vaccines for preventing intestinal infections (literature review)].
    Kheĭfets LB
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):21-8. PubMed ID: 4208437
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intracutaneous vaccination technic with less side effects against typhoid and cholera].
    Peltola H; Ruutu P; Palomäki H; Kaukinen K; Aho K
    Duodecim; 1977; 93(7):431-8. PubMed ID: 322994
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 76():47-53. PubMed ID: 2102020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Principles for the state control of oral vaccines against bacterial intestinal infections].
    Thilo W
    Z Gesamte Hyg; 1975; 21(12):888-91. PubMed ID: 820097
    [No Abstract]   [Full Text] [Related]  

  • 29. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities.
    Viret JF; Favre D
    Biologicals; 1994 Dec; 22(4):361-72. PubMed ID: 7540016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK
    Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a live oral typhoid vaccine in human volunteers.
    Hornick RB; DuPont HL; Levine MM; Gilman RH; Woodward WE; Snyder MJ; Woodward TE
    Dev Biol Stand; 1976; 33():89-92. PubMed ID: 782976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of diarrhoeal diseases.
    Martinez CA; Barua D; Merson MH
    World Health Stat Q; 1988; 41(2):74-81. PubMed ID: 3176516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [General immune reactions in man following oral administration of acetone-inactivated typhoid vaccines. II].
    Karolcek J; Draskovicová M; Greorch D; Mikulková V; Luzová D
    Zentralbl Bakteriol Orig; 1969; 211(4):502-10. PubMed ID: 4916992
    [No Abstract]   [Full Text] [Related]  

  • 37. Controlled field trial of a high-dose oral killed typhoid vaccine in India.
    Chuttani CS; Prakash K; Gupta P; Grover V; Kumar A
    Bull World Health Organ; 1977; 55(5):643-4. PubMed ID: 338191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New vaccines against enteric bacteria for children in less developed countries.
    Walker RI
    Expert Rev Vaccines; 2005 Dec; 4(6):807-12. PubMed ID: 16372876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of diarrhoea related vaccines.
    Sarkar SK; Pal SC
    Indian J Public Health; 1990; 34(1):20-34. PubMed ID: 1966245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with registered mucosal vaccines.
    Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF
    Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.